Stockscreener 앱 받기
10.10
3.27%
0.32
시간 외 거래:
10.30
0.20
+1.98%
전일 마감가:
$9.78
열려 있는:
$9.6
하루 거래량:
3.06M
Relative Volume:
0.90
시가총액:
$1.30B
수익:
$628.25M
순이익/손실:
$-78.55M
주가수익비율:
-16.29
EPS:
-0.62
순현금흐름:
$-29.73M
1주 성능:
+1.81%
1개월 성능:
+10.99%
6개월 성능:
+31.17%
1년 성능:
-28.57%
1일 변동 폭
$9.60
$10.28
1주일 범위
$9.42
$10.58
52주 변동 폭
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
명칭
Neogenomics Inc
전화
(239) 768-0600
주소
9490 NEOGENOMICS WAY, FORT MYERS, FL
NEO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
10.10 | 1.27B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-29 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 개시 | Guggenheim | Neutral |
| 2025-04-30 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 개시 | Jefferies | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-08-21 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-02-24 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-02-01 | 업그레이드 | Needham | Hold → Buy |
| 2022-08-26 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-22 | 다운그레이드 | Needham | Buy → Hold |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-03-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-29 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 재개 | Stephens | Overweight |
| 2021-12-16 | 개시 | Cowen | Outperform |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-25 | 재개 | Needham | Buy |
| 2021-02-25 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-12-11 | 재개 | BTIG Research | Buy |
| 2020-10-28 | 재확인 | Needham | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-08-28 | 개시 | Guggenheim | Buy |
| 2020-07-29 | 재확인 | Needham | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Buy |
| 2020-04-21 | 재개 | Stephens | Overweight |
| 2020-03-02 | 재개 | Craig Hallum | Buy |
| 2020-02-28 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-01 | 재확인 | Needham | Buy |
| 2019-03-29 | 재확인 | Needham | Buy |
| 2019-01-03 | 개시 | Needham | Buy |
| 2018-10-24 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 개시 | Leerink Partners | Outperform |
| 2018-05-02 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2017-08-24 | 개시 | Gabelli & Co | Buy |
| 2016-12-15 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Neogenomics Inc 주식(NEO)의 최신 뉴스
Using RSI to spot recovery in NeoGenomics Inc.Bull Run & Daily Risk Controlled Trade Plans - newser.com
Will earnings trigger a reversal in NeoGenomics Inc.2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
How NeoGenomics Inc. stock compares to growth peersWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Will a bounce in NeoGenomics Inc. offer an exitJuly 2025 Reactions & High Accuracy Investment Signals - newser.com
Chart overlay techniques for tracking NeoGenomics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - newser.com
Sector ETF performance correlation with NeoGenomics Inc.Weekly Volume Report & Fast Gain Swing Alerts - newser.com
Developing predictive dashboards with NeoGenomics Inc. dataJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Will NeoGenomics Inc. (NG9) stock announce a stock splitMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
Price momentum metrics for NeoGenomics Inc. explained2025 Volatility Report & Expert Curated Trade Setups - newser.com
Is NeoGenomics Inc. trending in predictive chart models2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
NeoGenomics Q3 2025 Earnings: Revenue Beat Offset by EPS Miss and Margin PressureNews and Statistics - IndexBox
How analysts rate NeoGenomics Inc. stock today2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call - Yahoo Finance
Technical analysis overview for NeoGenomics Inc. stockJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Is NeoGenomics Inc. (NG9) stock supported by free cash flow2025 Price Momentum & Weekly High Potential Alerts - newser.com
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Is NeoGenomics Inc. stock affected by interest rate hikesEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
Candlestick signals on NeoGenomics Inc. stock todayTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will NeoGenomics Inc. price bounce be sustainableJuly 2025 EndofMonth & Safe Capital Growth Tips - newser.com
Will NeoGenomics Inc. stock recover faster than marketJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Price action breakdown for NeoGenomics Inc.2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
Will NeoGenomics Inc. (NG9) stock keep raising dividendsQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Tools to assess NeoGenomics Inc.’s risk profileRecession Risk & Verified High Yield Trade Plans - newser.com
Is NeoGenomics Inc. stock a bargain at current levelsEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
NeoGenomics, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo
How hedge fund analytics apply to NeoGenomics Inc. stockBear Alert & Low Risk High Reward Trade Ideas - newser.com
How to track smart money flows in NeoGenomics Inc.Jobs Report & Free Technical Pattern Based Buy Signals - newser.com
Visualizing NeoGenomics Inc. stock with heatmapsJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Forecasting NeoGenomics Inc. price range with options dataJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
NeoGenomics to present RaDaR ST bridging study at ISLB 2025 - MSN
Will NeoGenomics Inc. stock gain from government policiesProfit Target & Intraday High Probability Setup Alerts - newser.com
Regression analysis insights on NeoGenomics Inc. performanceJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN
How NeoGenomics Inc. (NG9) stock responds to bond marketJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com
NeoGenomics Inc. Earnings Call: Clinical Growth Amid Pharma Challenges - MSN
Neogenomics Inc (NEO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
6.29%
자본화:
|
볼륨(24시간):